Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
The rise of pharma ad tech
Insiders say it comes at the cost of legacy platforms such as DSPs and SSPs.
Nike says it expects $986 million in IEEPA tariff refunds
The company said its North America business expects to recover $965 million in tariff refunds from the U.S. government.
Digiday+ Research: The marketers’ 2026 guide to creator marketing, including Duolingo, Ulta and YouTube
While Instagram, TikTok and YouTube remain dominant social platforms for influencer partnerships, creators are increasingly being used across other media channels, including retail media, CTV and display ads.